Resolving genetic heterogeneity in cancer

S Turajlic, A Sottoriva, T Graham… - Nature Reviews Genetics, 2019 - nature.com
To a large extent, cancer conforms to evolutionary rules defined by the rates at which clones
mutate, adapt and grow. Next-generation sequencing has provided a snapshot of the …

Clinical actionability of molecular targets in endometrial cancer

ME Urick, DW Bell - Nature Reviews Cancer, 2019 - nature.com
Abstract Endometrial cancer accounts for~ 76,000 deaths among women each year
worldwide. Disease mortality and the increasing number of new diagnoses make …

Pan-cancer whole-genome analyses of metastatic solid tumours

P Priestley, J Baber, MP Lolkema, N Steeghs… - Nature, 2019 - nature.com
Metastatic cancer is a major cause of death and is associated with poor treatment efficacy. A
better understanding of the characteristics of late-stage cancer is required to help adapt …

The genetic evolution of metastatic uveal melanoma

AH Shain, MM Bagger, R Yu, D Chang, S Liu… - Nature …, 2019 - nature.com
Uveal melanoma is a clinically distinct and particularly lethal subtype of melanoma
originating from melanocytes in the eye. Here, we performed multi-region DNA sequencing …

An analysis of genetic heterogeneity in untreated cancers

JG Reiter, M Baretti, JM Gerold… - Nature Reviews …, 2019 - nature.com
Genetic intratumoural heterogeneity is a natural consequence of imperfect DNA replication.
Any two randomly selected cells, whether normal or cancerous, are therefore genetically …

Randomized trials and endpoints in advanced HCC: role of PFS as a surrogate of survival

JM Llovet, R Montal, A Villanueva - Journal of hepatology, 2019 - Elsevier
Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality worldwide.
Around half of patients with HCC will receive systemic therapies during their life span. The …

Applications of liquid biopsies for cancer

AK Mattox, C Bettegowda, S Zhou… - Science translational …, 2019 - science.org
Applications of liquid biopsies for cancer | Science Translational Medicine news careers
commentary Journals Science Science brought to you byGoogle Indexer Log in science science …

Circulating tumor DNA as a clinical test in resected pancreatic cancer

VP Groot, S Mosier, AA Javed, JA Teinor… - Clinical Cancer …, 2019 - AACR
Purpose: In research settings, circulating tumor DNA (ctDNA) shows promise as a tumor-
specific biomarker for pancreatic ductal adenocarcinoma (PDAC). This study aims to perform …

Cellular and molecular mechanisms underlying prostate cancer development: therapeutic implications

U Testa, G Castelli, E Pelosi - Medicines, 2019 - mdpi.com
Prostate cancer is the most frequent nonskin cancer and second most common cause of
cancer-related deaths in man. Prostate cancer is a clinically heterogeneous disease with …

Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

N Sundahl, G Vandekerkhove, K Decaestecker… - European urology, 2019 - Elsevier
Preclinical data indicate that radiotherapy works synergistically with pembrolizumab, but the
effect and toxicity of this combination may depend on radiotherapy timing. We conducted a …